Wall Street's Monday Calls Split AI Winners From Cyclical Laggards

Analysts upgraded CoreWeave, Datadog and Intel while cutting several financial, consumer and travel names. The dispersion matters more than the headline count because target changes often reflected very different business risks.
Monday's analyst calls produced a clear split: several AI and cloud-linked companies received upgrades, while financial, consumer and travel names faced more cautious ratings. The list is not a unified market signal. Each call reflects a firm's assumptions about earnings, valuation and industry conditions, and some target changes moved in the opposite direction from the rating.
Goldman Sachs upgraded CoreWeave to Buy from Neutral with a $106 target, while Bernstein raised Datadog to Outperform from Market Perform and increased its target to $350 from $237. Both calls point toward continued willingness to pay for infrastructure and software exposure to cloud and AI demand. That does not remove company-specific risks. CoreWeave remains capital intensive and highly leveraged, while Datadog still must convert product expansion into durable revenue growth.
JPMorgan's Intel move was more restrained. The firm lifted Intel to Neutral from Underweight but kept its $85 target unchanged. A neutral rating can signal that downside concerns have eased without asserting that the shares offer compelling upside. The same nuance appears in Morgan Stanley's Boyd Gaming call: the rating rose to Overweight from Equal Weight even as the target fell to $83 from $89.
The downgrades covered several unrelated problems. Bank of America moved Ameriprise Financial from Buy to Underperform and cut its target to $445 from $570. Stifel reduced LCI Industries to Hold from Buy and lowered its target to $80 from $130. Cleveland Research cut PayPal to Underperform, while Longbow moved Whirlpool to Neutral. UBS upgraded JetBlue to Neutral from Sell but reduced its target to $3.50 from $4, another reminder that a higher rating does not necessarily mean a stronger earnings outlook.
New coverage added still more variety. Canaccord began Maze Therapeutics at Buy with a $75 target, Phillip Securities started Pinterest at Buy with a $30 target, and Morgan Stanley initiated Rush Street Interactive at Equal Weight with a $22 target. These are starting opinions, not changes based on a newly reported quarter.
For investors, the useful task is to identify what assumption changed. A rating alone compresses a multi-year model into one word. Target-price direction, earnings revisions, balance-sheet risk and the time horizon can tell a different story. Monday's calls favored selected AI and cloud exposures, but the simultaneous caution elsewhere shows that analysts were discriminating among business models rather than making one broad market bet.
Continue your CRWV research
Related News
Nvidia's AI Reach Is Systemically Important, but No Bailout Is Guaranteed
Nvidia's role as chip supplier, investor and index heavyweight makes it unusually important to the AI economy. That interconnection can spread shocks, but it does not protect shareholders or imply a government rescue.
Vertiv’s Selloff Puts Orders, Not Analyst Targets, in Focus
Vertiv fell nearly 14% in a week as financing concerns spread across AI infrastructure. The lower valuation may look attractive, but orders and backlog at the October 28 earnings report are the decisive test.
Nasdaq Futures Slip as AI Earnings Face an Expensive Capital Test
Nasdaq futures weakened before a dense earnings slate as investors weighed costly AI infrastructure, higher oil prices and company-specific risks. The move was caution, not a broad market collapse.
Three Stocks Hit New Lows, but the Risks Were Very Different
EyePoint, CoreWeave and Eos Energy touched new lows on the same day. The selloffs reflected three distinct problems: a failed pivotal trial, financing pressure and manufacturing execution risk.
Reddit's 61% Growth Supports Its Premium, but the Next Quarter Slows
Reddit's second-quarter revenue rose 61% and weekly active uniques reached 514.6 million, supporting a richer valuation than slower-growing peers. Management's third-quarter guide, however, implies a clear deceleration and leaves search traffic as a risk.
Moderna, Coca-Cola and Visa Hit Highs for Three Very Different Reasons
Moderna, Coca-Cola and Visa reached new highs on separate catalysts: cancer-vaccine expectations, a KFC beverage deal and services growth. The shared price milestone does not make the underlying investment cases comparable.















Latest comments